XML 78 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2

Earnings per share (Tables)

12 Months Ended

Jun. 30, 2022

Text block [abstract]

Summary of earnings per share

		2022 A$’000				2021 A$’000				2020 A$’000
Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(24,648	)			(8,422	)			(12,467	)
Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(24,648	)			(8,422	)			(12,467	)
		Number				Number				Number
Weighted average number of ordinary shares used in calculating basic earnings per share			132,467,686				117,674,543				73,053,514
Weighted average number of ordinary shares used in calculating Diluted earnings per share			132,467,686				117,674,543				73,053,514
		Cents				Cents				Cents
Basic earnings per share			(18.61	)			(7.16	)			(17.07	)
Diluted earnings per share			(18.61	)			(7.16	)			(17.07	)

X

- Definition

The disclosure of earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2021-01-01
-Paragraph 66
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_EarningsPerShareExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Text block [abstract]

+ References

No definition available.

+ Details

Name:	kzia_TextBlockAbstract
Namespace Prefix:	kzia_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration